117 related articles for article (PubMed ID: 33433358)
1. The critical roles of lncRNAs in the development of osteosarcoma.
Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M
Biomed Pharmacother; 2021 Mar; 135():111217. PubMed ID: 33433358
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA
Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analyses of XRN1-sensitive targets in osteosarcoma cells identify disease-relevant transcripts containing G-rich motifs.
Pashler AL; Towler BP; Jones CI; Haime HJ; Burgess T; Newbury SF
RNA; 2021 Oct; 27(10):1265-1280. PubMed ID: 34266995
[TBL] [Abstract][Full Text] [Related]
4. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
Polvani S; Martignano F; Scoccianti G; Pasqui A; Palomba AR; Conticello S; Galli A; Palchetti I; Caporalini C; Antonuzzo L; Campanacci DA; Pillozzi S
Anticancer Drugs; 2022 Mar; 33(3):278-285. PubMed ID: 35045526
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma.
Rothzerg E; Ho XD; Xu J; Wood D; Märtson A; Kõks S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440306
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
Song XJ; Bi MC; Zhu QS; Liu XL
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
[TBL] [Abstract][Full Text] [Related]
7. LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR-516b-5p/Gli1 axis.
Pan X; Tan J; Tao T; Zhang X; Weng Y; Weng X; Xu J; Li H; Jiang Y; Zhou D; Shen Y
Cancer Sci; 2021 Jun; 112(6):2260-2271. PubMed ID: 33837611
[TBL] [Abstract][Full Text] [Related]
8. LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression.
Yao W; Hou J; Liu G; Wu F; Yan Q; Guo L; Wang C
Cancer Biomark; 2023; 36(1):1-16. PubMed ID: 35912730
[TBL] [Abstract][Full Text] [Related]
9. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
[TBL] [Abstract][Full Text] [Related]
10. A risk assessment model for the prognosis of osteosarcoma utilizing differentially expressed lncRNAs.
Sun K; Zhao J
Mol Med Rep; 2019 Feb; 19(2):1128-1138. PubMed ID: 30569146
[TBL] [Abstract][Full Text] [Related]
11. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
He T; Yuan C; Zhao C
Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
[TBL] [Abstract][Full Text] [Related]
12. The interaction between miRNAs/lncRNAs and Notch pathway in human disorders.
Ghafouri-Fard S; Glassy MC; Abak A; Hussen BM; Niazi V; Taheri M
Biomed Pharmacother; 2021 Jun; 138():111496. PubMed ID: 33743335
[TBL] [Abstract][Full Text] [Related]
13. RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells.
Chang J; Ma X; Sun X; Zhou C; Zhao P; Wang Y; Yang Y
J Vis Exp; 2023 Jun; (196):. PubMed ID: 37395584
[TBL] [Abstract][Full Text] [Related]
14. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment.
Fu R; Hong X
Biomed Res Int; 2022; 2022():3113857. PubMed ID: 35528175
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract][Full Text] [Related]
16. Combination of hsa_circ_0004674 and lncRNA OIP5‑AS1 as a novel clinical biomarker used to predict prognosis in patients with osteosarcoma.
Zhu YR; Zhu KP; Hu JP; Tan S; Zhang CL
Exp Ther Med; 2023 May; 25(5):208. PubMed ID: 37090082
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
Momtazmanesh S; Rezaei N
Front Oncol; 2021; 11():712786. PubMed ID: 34322395
[TBL] [Abstract][Full Text] [Related]
18. lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach.
Guzmán-Martín CA; Juárez-Vicuña Y; Domínguez-López A; González-Ramírez J; Amezcua-Guerra LM; Martínez-Martínez LA; Sánchez-Muñoz F
Mol Biol Rep; 2023 Jan; 50(1):937-941. PubMed ID: 36367661
[TBL] [Abstract][Full Text] [Related]
19. Emerging Role of Non-coding RNAs in Autism Spectrum Disorder.
Ghafouri-Fard S; Noroozi R; Brand S; Hussen BM; Eghtedarian R; Taheri M; Ebrahimzadeh K
J Mol Neurosci; 2022 Feb; 72(2):201-216. PubMed ID: 34767189
[TBL] [Abstract][Full Text] [Related]
20. LncRNAs: Novel Biomarkers for Pancreatic Cancer.
Ghafouri-Fard S; Fathi M; Zhai T; Taheri M; Dong P
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
